BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2608583)

  • 21. Galactorrhea: a study of 235 cases, including 48 with pituitary tumors.
    Kleinberg DL; Noel GL; Frantz AG
    N Engl J Med; 1977 Mar; 296(11):589-600. PubMed ID: 840242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracranial dissemination of a macroprolactinoma.
    Assies J; Verhoeff NP; Bosch DA; Hofland LJ
    Clin Endocrinol (Oxf); 1993 May; 38(5):539-46. PubMed ID: 8101148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolactinomas in children and adolescents. Clinical presentation and long-term follow-up.
    Colao A; Loche S; Cappa M; Di Sarno A; Landi ML; Sarnacchiaro F; Facciolli G; Lombardi G
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2777-80. PubMed ID: 9709946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology and Management Challenges in Prolactinomas.
    Vroonen L; Daly AF; Beckers A
    Neuroendocrinology; 2019; 109(1):20-27. PubMed ID: 30731464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolactinomas.
    Glezer A; Bronstein MD
    Endocrinol Metab Clin North Am; 2015 Mar; 44(1):71-8. PubMed ID: 25732643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of cyproterone acetate, LHRH agonist and ovarian surgery in McCune-Albright syndrome with precocious puberty and galactorrhea.
    Carani C; Pacchioni C; Baldini A; Zini D
    J Endocrinol Invest; 1988 Jun; 11(6):419-23. PubMed ID: 2974851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment strategy of pituitary invasive prolactinomas].
    Wu ZB; Yu CJ
    Zhonghua Wai Ke Za Zhi; 2009 Jan; 47(2):123-7. PubMed ID: 19563008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Giant prolactinomas larger than 60 mm in size: a cohort of massive and aggressive prolactin-secreting pituitary adenomas.
    Shimon I; Sosa E; Mendoza V; Greenman Y; Tirosh A; Espinosa E; Popovic V; Glezer A; Bronstein MD; Mercado M
    Pituitary; 2016 Aug; 19(4):429-36. PubMed ID: 27138902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Malignant prolactinoma.
    Berezin M; Gutman I; Tadmor R; Horowitz A; Findler G
    Acta Endocrinol (Copenh); 1992 Nov; 127(5):476-80. PubMed ID: 1471460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolactinomas in children under 14. Clinical presentation and long-term follow-up.
    Liu Y; Yao Y; Xing B; Lian W; Deng K; Feng M; Wang R
    Childs Nerv Syst; 2015 Jun; 31(6):909-16. PubMed ID: 25771923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 10-year follow-up study comparing primary medical vs. surgical therapy in women with prolactinomas.
    Andereggen L; Frey J; Andres RH; El-Koussy M; Beck J; Seiler RW; Christ E
    Endocrine; 2017 Jan; 55(1):223-230. PubMed ID: 27688009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Galactorrhoea and pituitary mass: a typical prolactinoma?
    Brändle M; Schmid C
    Postgrad Med J; 2000 Apr; 76(894):232-4. PubMed ID: 10727570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A prolactin-producing microadenoma as the cause of galactorrhea and delayed puberty in an adolescent boy].
    Böhles H; Fahlbusch R; Becker H; Schill WB; Stehr K
    Monatsschr Kinderheilkd; 1983 Oct; 131(10):736-9. PubMed ID: 6685820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Update on prolactinomas. Part 2: Treatment and management strategies.
    Wong A; Eloy JA; Couldwell WT; Liu JK
    J Clin Neurosci; 2015 Oct; 22(10):1568-74. PubMed ID: 26243714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intestinal pseudo obstruction with galactorrhoea.
    Kumaravelu S; Narayanan VA; Gopinathan VP; Dhingra A; Bhalla IP; Krishnan NR
    J Assoc Physicians India; 1989 Apr; 37(4):275-7. PubMed ID: 2613622
    [No Abstract]   [Full Text] [Related]  

  • 36. Multidisciplinary treatment of giant invasive prolactinomas in paediatric age: long-term follow-up in two children.
    Fraioli MF; Novegno F; Catena E; Fraioli C; Moschettoni L
    Childs Nerv Syst; 2010 Sep; 26(9):1233-7. PubMed ID: 20352234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of resistant prolactinomas.
    Olafsdottir A; Schlechte J
    Nat Clin Pract Endocrinol Metab; 2006 Oct; 2(10):552-61. PubMed ID: 17024154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pituitary adenomas (prolactinomas) and amenorrhea-galactorrhea].
    van der Merwe JV
    S Afr Med J; 1981 Jan; 59(5):137-40. PubMed ID: 7006109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intestinal pseudo obstruction with galactorrhoea.
    Patwardhan MH
    J Assoc Physicians India; 1989 Nov; 37(11):730-1. PubMed ID: 2632549
    [No Abstract]   [Full Text] [Related]  

  • 40. Current approach to treatments for prolactinomas.
    Tirosh A; Shimon I
    Minerva Endocrinol; 2016 Sep; 41(3):316-23. PubMed ID: 26399371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.